Chair 2022-2025

Professor Giuseppe CARDILLO, FRCS, FETCS is the chair of Thoracic Surgery at Azienda Ospedaliera San Camillo Forlanini in Rome, Italy. He is The President of the Italian Society of Thoracic Endoscopy ( SIET) ; the Chair of ERS( European Respiratory Society) Thoracic Surgery Group 08.1; the Director of EACTS ( European Association for CardioThoracic Surgery) Academy Thoracic Surgery Course 1. He is councillor of ITMIG ( International Thymic Malignancies Interest Group) and member of the “ Staging and Prognostic Factors Committee” of the IASLC , involved in Nodal Staging update . He is co-chair of The “Pneumothorax “ ERS-EACTS-ESTS joint task force, of the “GGO “ EACTS-ESTS task force, and of the ERS Benign pleural effusion task force. He has been co-chair of the ERS-EACTS -ESTS-ESTRO Malignant pleural Mesothelioma task force. He is Associate Editor of Frontiers in Oncology , and Guest Editor of Journal of Clinical Medicine ; he is also editorial board member of European Respiratory Journal (ERJ) ( IF 33.8) In the past, he has been Locum Consultant Thoracic surgeon at University Hospitals of Leicester , Glenfield Hospital , Leicester(UK)( 2007) and Fellow Thoracic Surgeon at Sahlgrenska University Hospital, Gothenburg (S) ( 1996). His main clinical interest is minimally invasive thoracic surgery either by VATS and by RATS ( robot Da Vinci Xi), locally advanced NSCLC , Mesothelioma, Thymoma, and tracheal surgery. He is also involved in lung cancer screening

Member 2022-2025

Member 2022-2025

Vincent (Wentao) Fang is the chief thoracic surgeon at the Shanghai Chest Hospital, Jiaotong University Medical School in Shanghai, China. He routinely performs open and minimally-invasive surgery including VATS and robotics for pulmonary, mediastinal and esophageal diseases. His research focuses on thoracic malignancies, including lung cancers, thymic tumors, and esophageal cancers. He is currently a Steering Committee member of the IASLC SPFC, Thoracic Domain member of the ASCVTS, Chairman of the Mediastinal Tumor committee and Vice Chairman of the Esophageal Cancer committee of the Chinese Anti-Cancer Association.

Member 2020-2023

Member 2022-2025

Member 2022-2023

Member 2022-2025

Akshay is a specialist registrar in thoracic surgery and clinical lecturer at the University of Birmingham. He is one of the Royal College of Surgeons Associate Surgical Specialty Leads (aSSL) in thoracic surgical research. Most recently he has completed his CRUK clinical training research fellowship in lab-based research exploring the immunobiology of Non-Small Cell Lung Cancer. He is an active researcher in Thoracic Surgery with particular interest in the translational aspect of lung cancer immunobiology and the impact of checkpoint blockade, minimally invasive surgery, thymic malignancy as well as disorders of the chest wall and airway.

Member 2022-2025

Dr. Sara Ricciardi is a consultant thoracic surgeon at San Camillo Forlanini Hospital in Rome and PhD student at Alma Mater Studiorum, University of Bologna, Italy. She finished her residency program at University of Pisa in December 2019, then she worked as fellow in Robotic Multidisciplinary Centre at University Hospital of Pisa, one of the most important centres in Europe, and spent three months at Toronto General Hospital to improve her skills on lung transplant and general thoracic surgery. She worked also at University Hospital of Bologna (May 2020-November 2021), one of the most important national centres for advanced thoracic oncologic surgery and lung transplant. She is an active researcher in Thoracic Surgery with particular interest in NSCLC, minimally invasive surgery, therapy of malignant pleural mesothelioma, thymic malignancies, pneumothorax, lymph nodal upstaging and lung transplant. She has attended at many conferences both as speaker and as moderator panelist. Thanks to her study on prognostic impact of N2 involvement in lung cancer she was a Young investigator award recipient at World conferences of Lung Cancer in 2016 and 2017 (IASLC-WCLC2016, 2017). Furthermore, her study on the prognostic role of the resection margin on long-term outcomes after lung metastasectomy, was awarded, in October 2020, with the Young Investigator award during the annual meeting of the European Society of Cardio-Thoracic Surgery (EACTS). Dr Ricciardi has been selected as the 2023 Francis Fontan Fund VATS in General Thoracic Surgery Fellow and she is going to spend three months in Odense University Hospital, Denmark. She is an active member of international society as International Association for the Study of Lung Cancer (IASLC), European Association for Cardio Thoracic Surgery (EACTS), European Respiratory Society (ERS), European Society of Thoracic Surgeon (ESTS) and of Italian society of thoracic surgery and endoscopy. She is a Junior Editorial board member of AMJ (AME Medical Journal) and Minimally invasive Surgery (MIS), she is also a reviser of several journals.

Domain Chair 2018-2021

Member 2021-2024

Eric Dominic Roessner graduated in 1999 as a medical doctor at the Johannes Gutenberg University Mainz, Germany. After graduation he moved to the University Medical Center in Mannheim, Germany and started his surgical training. In 2005 he took the German board for general surgery. Subsequently he started his training in advanced abdominal surgery with a focus on upper GI surgery. He interrupted his training in 2007 and started his Thoracic surgery training. In 2009 2010 he changed to start a senior fellowship in the Royal Brompton Hospital, London, UK. In 2010 he returned to Mannheim and was appointed as a Consultant Surgeon for Thoracic and General Surgery. In 2014 he took the European Boards of Thoracic Surgery and completed his GI training in 2017 and took the German Boards for Advanced Abdominal Surgery. His academic activities in the field of tissue engineering lead to his appointment as an assistant professor in 2014, in 2018 he was appointed as a full professor now focusing in the field of hybrid operating technologies. In 2019 he was appointed as the head of Thoracic Surgery in the University Hospital Mainz, Germany, and became the Speaker of the Steering Committee of the Department of Cardio- Thoracic Surgery. He clinical focus is the minimal invasive treatment (uniportal VATS) of lung cancer, thoracic sarcoma and tumours of the mediastinum with a focus on robotic surgery.